Can severe pulmonary hypertension cause atrial fibrillation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Severe Pulmonary Hypertension as a Cause of Atrial Fibrillation

Yes, severe pulmonary hypertension can cause atrial fibrillation through multiple pathophysiological mechanisms including atrial remodeling, increased atrial pressure, and right heart dysfunction.

Pathophysiological Mechanisms

Severe pulmonary hypertension leads to atrial fibrillation through several key mechanisms:

  1. Atrial Stretch and Remodeling

    • Elevated pulmonary pressures cause right atrial enlargement and stretching
    • Mechanical stress triggers electrical remodeling of atrial tissue 1
    • Structural changes in the atria create a substrate for re-entry circuits
  2. Hemodynamic Changes

    • Increased right atrial pressure due to pulmonary hypertension
    • Right ventricular hypertrophy and dysfunction
    • Eventual left atrial involvement through interventricular interdependence
  3. Neurohormonal Activation

    • Activation of the renin-angiotensin-aldosterone system (RAAS)
    • Increased sympathetic tone
    • These changes promote atrial electrical instability 1

Epidemiological Evidence

The relationship between pulmonary hypertension and atrial fibrillation is well-established in clinical guidelines:

  • Supraventricular arrhythmias occur in advanced pulmonary hypertension, with atrial flutter and atrial fibrillation having a cumulative incidence of 25% after 5 years 1
  • Atrial fibrillation in pulmonary hypertension patients indicates more advanced disease 2
  • The 2015 ESC/ERS guidelines specifically mention atrial fibrillation as a complication of advanced pulmonary hypertension 1

Clinical Implications

The development of atrial fibrillation in pulmonary hypertension patients has significant clinical consequences:

  • Hemodynamic Compromise: Atrial fibrillation causes loss of atrial contraction and irregular ventricular filling, which is particularly detrimental in pulmonary hypertension where right ventricular function is already compromised
  • Disease Progression: Atrial fibrillation can accelerate the progression of pulmonary hypertension 2
  • Increased Morbidity: Patients with both conditions have worse outcomes than those with either condition alone

Management Considerations

When atrial fibrillation develops in a patient with pulmonary hypertension:

  • Prompt recognition and treatment are essential as inadequate control leads to poor clinical outcomes 2
  • Rate control is particularly important as tachycardia can worsen right ventricular function
  • Anticoagulation should be considered due to the increased risk of thromboembolism
  • Catheter ablation may be considered in selected cases, though outcomes may be less favorable than in patients without pulmonary hypertension 3

Risk Factors and Prevention

Several factors increase the risk of atrial fibrillation in pulmonary hypertension:

  • Severity of pulmonary hypertension
  • Right atrial dilation
  • Right ventricular dysfunction
  • Coexisting conditions like hypoxemia

Early detection of pulmonary hypertension and optimal management may help prevent the development of atrial fibrillation by limiting right heart remodeling and dysfunction.

Conclusion

The evidence clearly demonstrates that severe pulmonary hypertension can cause atrial fibrillation through multiple mechanisms. Recognizing this relationship is crucial for optimal management of patients with pulmonary hypertension, as the development of atrial fibrillation signifies disease progression and requires prompt intervention to prevent further hemodynamic deterioration.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.